Affymetrix, MicroChips, Amersham Biosciences, Cartesian Technologies, Roche Diagnostics, Helix BioPharma | GenomeWeb

Affymetrix received US Patent No. 6,551,784, “Method of comparing nucleic acid sequences.” The patent covers a system for comparing and identifying differences in nucleic acid sequences and is an extension of the Santa Clara, Calif., company’s tract of intellectual property surrounding its methods of microarray analysis of gene expression. The company also received US Patent No. 6,551,817, “Method and apparatus for hybridization.” This patent covers a packaging system for a device containing probe molecules and methods for introducing fluids into it.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.